[1] SUBARAJAN P, ARCEO-MENDOZA RM, CAMACCHO PM, et al. Postmenopausal Osteoporosis: A Review of Latest Guidelines. Endocrinol Metab Clin North Am. 2024;53(4):497-512.
[2] LU B, HAN Q, ZHAO S, et al. Associations between hormones, metabolic markers, and bone mass in perimenopausal and postmenopausal women. J Bone Miner Metab. 2025;43(4):392-401.
[3] VERMA A, MALHOTRA A, RANJAN P, et al. A comprehensive evaluation of predictors of obesity in women during the perimenopausal period: A systematic review and narrative synthesis. Diabetes Metab Syndr. 2024;18(1):102933.
[4] PALACIOS S, CHEDRAUI P, SANCHEZ-BORREGO R, et al. Management of obesity in menopause. Climacteric. 2024;27(4):357-363.
[5] URALDE ER, SOBEL TH, MANSON JE, et al. Management of perimenopausal and menopausal symptoms. BMJ. 2023;382:e072612.
[6] YELLAND S, STEENSON S, CREEDON A, et al. The role of diet in managing menopausal symptoms: A narrative review. Nutr Bull. 2023; 48(1):43-65.
[7] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691.
[8] 刘功稳,朱柯雨,陆政峰,等.骨质疏松症和骨质疏松性骨折防治的现状及挑战[J].中华骨质疏松和骨矿盐疾病杂志,2024,17(5): 409-418.
[9] LONG G, LIU C, LIANG T, et al. Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis. J Orthop Surg Res. 2023; 18(1):574.
[10] HARRIS K, ZAGAR CA, LAWRENCE KV. Osteoporosis: Common Questions and Answers. Am Fam Physician. 2023;107(3):238-246.
[11] CRANNEY A, WALDEGGER L, ZYTARUK N, et al. Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cochrane Database Syst Rev. 2003;(4):CD004523.
[12] PERDOMO CM, Cohen RV, SUMITHRAN P, et al. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023; 401(10382):1116-1130.
[13] CHEN R, ARMAMENTO-VILLAREAL R. Obesity and Skeletal Fragility. J Clin Endocrinol Metab. 2024;109(2):e466-e477.
[14] MARTINIAKOVA M, BIRO R, PENZES N, et al. Links among Obesity, Type 2 Diabetes Mellitus, and Osteoporosis: Bone as a Target. Int J Mol Sci. 2024;25(9):4827.
[15] LU Y, LIU S, QIAO Y, et al. Waist-to-height ratio, waist circumference, body mass index, waist divided by height0.5 and the risk of cardiometabolic multimorbidity: A national longitudinal cohort study. Nutr Metab Cardiovasc Dis. 2021;31(9):2644-2651.
[16] HE HM, XIE YY, CHEN Q, et al. The synergistic effect of the triglyceride-glucose index and a body shape index on cardiovascular mortality: the construction of a novel cardiovascular risk marker. Cardiovasc Diabetol. 2025;24(1):69.
[17] ZHANG A, LI Y, MA S, et al. Conicity-index predicts all-cause mortality in Chinese older people: a 10-year community follow-up. BMC Geriatr. 2022;22(1):971.
[18] DEMIRBAS N, KUTLU R. Importance of Measured Body Fat, Visceral Adiposity Index, and Lipid Accumulation Product Index in Predicting Cardiometabolic Risk Factors. Metab Syndr Relat Disord. 2021;19(3):174-179.
[19] WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
[20] TURCOTTE AF, O’CONNOR S, MORIN SN, et al. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: A systematic review and meta-analysis. PLoS One. 2021; 16(6):e0252487.
[21] SALAMAT MR, SALAMAT AH, JANGHORBANI M. Association between Obesity and Bone Mineral Density by Gender and Menopausal Status. Endocrinol Metab (Seoul). 2016;31(4):547-558.
[22] MA M, FENG Z, LIU X, et al. The Saturation Effect of Body Mass Index on Bone Mineral Density for People Over 50 Years Old: A Cross-Sectional Study of the US Population. Front Nutr. 2021;8:763677.
[23] GRECO EA, FORNARI R, ROSSI F, et al. Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int J Clin Pract. 2010;64(6):817-820.
[24] JOSE A, CHERIAN KE, NANDYAL MB, et al. Trabecular Bone Score and Bone Mineral Density in Postmenopausal Women with Morbid Obesity-A Clinical Paradox. Med Sci (Basel). 2021;9(4):69.
[25] LI Y. Association between obesity and bone mineral density in middle-aged adults. J Orthop Surg Res. 2022;17(1):268.
[26] LESLIE WD, ORWOLL ES, NIELSON CM, et al. Estimated lean mass and fat mass differentially affect femoral bone density and strength index but are not FRAX independent risk factors for fracture. J Bone Miner Res. 2014;29(11):2511-2519.
[27] ODE J, KNOUS J, SCHLAFF R, et al. Accuracy of body mass index in volunteer firefighters. Occup Med (Lond). 2014;64(3):193-197.
[28] ZHAO Z, JI H, LIU W, et al. The saturation effect of a body shape index on lumbar bone mineral density in US adults: Findings from a nationwide survey. PLoS One. 2025;20(6):e0324160.
[29] KIM B, KIM GM, KIM E, et al. The Anthropometric Measure ‘A Body Shape Index’ May Predict the Risk of Osteoporosis in Middle-Aged and Older Korean People. Int J Environ Res Public Health. 2022;19(8):4926.
[30] DENG G, YIN L, LI K, et al. Relationships between anthropometric adiposity indexes and bone mineral density in a cross-sectional Chinese study. Spine J. 2021;21(2):332-342.
[31] 邓桂娟,程晓光,尹潞,等.中老年高血压人群肥胖与骨质疏松相关性研究[J].中国循环杂志,2019,34(11):1091-1097.
[32] CIOVACCO WA, GOLDBERG CG, TAYLOR AF, et al. The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiation. Bone. 2009;44(1):80-86.
[33] KIM HL, CHO HY, PARK IY, et al. The positive association between peripheral blood cell counts and bone mineral density in postmenopausal women. Yonsei Med J. 2011;52(5):739-745.
[34] 张金鹏,陈畅,潘秋予,等.中老年人群血小板计数与腰椎骨密度的相关性[J].中国组织工程研究,2023,27(31):5046-5051.
[35] KRISTJANSDOTTIR HL, MELLSTROM D, JOHANSSON P, et al. High platelet count is associated with low bone mineral density: The MrOS Sweden cohort. Osteoporos Int. 2021;32(5):865-871.
[36] ZHANG Y, ZHAO B, HUANG Z, et al. Sex-specific association between platelet content and bone mineral density in adults: a cross-sectional study. BMC Musculoskelet Disord. 2024;25(1):875.
[37] 朱玲,李倩,翟建,等.中老年体检女性血常规指标与定量CT腰椎骨密度的相关性研究[J].中国骨质疏松杂志,2022,28(12): 1787-1790.
[38] KHAN FA, PARAYARUTHOTTAM P, ROSHAN G, et al. Platelets and Their Pathways in Dentistry: Systematic Review. J Int Soc Prev Community Dent. 2017;7(Suppl 2):S55-S60.
[39] HUANG Y, YE J. Association between hypertension and osteoporosis: a population-based cross-sectional study. BMC Musculoskelet Disord. 2024;25(1):434.
[40] YE Z, LU H, LIU P. Association between essential hypertension and bone mineral density: a systematic review and meta-analysis. Oncotarget. 2017;8(40):68916-68927.
[41] CHAI H, GE J, LI L, et al. Hypertension is associated with osteoporosis: a case-control study in Chinese postmenopausal women. BMC Musculoskelet Disord. 2021;22(1):253.
[42] 张栋楠,马春芬,王国华,等.男性高血压患者QCT检测与腰椎骨密度的相关性[J].中国骨质疏松杂志,2022,28(10):1476-1479,1484.
[43] 杜亚玮,戚昕,周阳,等.不同性别人群定量CT骨密度与血压和血脂的相关性分析[J].放射学实践,2025,40(2):248-253.
[44] CHEN X, HE B, ZHOU Y, et al. Investigating the effect of history of fractures and hypertension on the risk of all-cause death from osteoporosis: A retrospective cohort study. Medicine (Baltimore). 2023; 102(13):e33342.
[45] YANG S, NGUYEN ND, CENTER JR, et al. Association between hypertension and fragility fracture: a longitudinal study. Osteoporos Int. 2014;25(1):97-103.
[46] VESTERGAARD P, PEJNMARK L, MOSEKILDE L. Hypertension is a risk factor for fractures. Calcif Tissue Int. 2009;84(2):103-111.
[47] GHADIRI-ANARI A, MOETEZAII-SHOROKI Z, MODARRESI M, et al. Association of lipid profile with bone mineral density in postmenopausal women in Yazd province. Int J Reprod Biomed. 2016;14(9):597-602.
[48] YANG P, LI D, LI X, et al. High-density lipoprotein cholesterol levels is negatively associated with intertrochanter bone mineral density in adults aged 50 years and older. Front Endocrinol (Lausanne). 2023; 14:1109427.
[49] ZOLFAROLI I, ORTIZ E, GARCIA-PEREZ MÁ, et al. Positive association of high-density lipoprotein cholesterol with lumbar and femoral neck bone mineral density in postmenopausal women. Maturitas. 2021;147:41-46.
[50] XIE R, HUANG X, LIU Q, et al. Positive association between high-density lipoprotein cholesterol and bone mineral density in U.S. adults: the NHANES 2011-2018. J Orthop Surg Res. 2022;17(1):92.
|